Cargando…
A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
Crimean-Congo Hemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15–70% of reported cases are fatal with no approved vaccine available. In the present study, the attenuated poxvirus vector, Modified Vaccinia...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049717/ https://www.ncbi.nlm.nih.gov/pubmed/26309231 http://dx.doi.org/10.1080/21645515.2015.1078045 |
_version_ | 1782457768163147776 |
---|---|
author | Dowall, SD Buttigieg, KR Findlay-Wilson, SJD Rayner, E Pearson, G Miloszewska, A Graham, VA Carroll, MW Hewson, R |
author_facet | Dowall, SD Buttigieg, KR Findlay-Wilson, SJD Rayner, E Pearson, G Miloszewska, A Graham, VA Carroll, MW Hewson, R |
author_sort | Dowall, SD |
collection | PubMed |
description | Crimean-Congo Hemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15–70% of reported cases are fatal with no approved vaccine available. In the present study, the attenuated poxvirus vector, Modified Vaccinia virus Ankara, was used to develop a recombinant candidate vaccine expressing the CCHF virus nucleoprotein. Cellular and humoral immunogenicity was confirmed in 2 mouse strains, including type I interferon receptor knockout mice, which are susceptible to CCHF disease. Despite the immune responses generated post-immunisation, the vaccine failed to protect animals from lethal disease in a challenge model. |
format | Online Article Text |
id | pubmed-5049717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-50497172016-10-12 A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease Dowall, SD Buttigieg, KR Findlay-Wilson, SJD Rayner, E Pearson, G Miloszewska, A Graham, VA Carroll, MW Hewson, R Hum Vaccin Immunother Research Papers Crimean-Congo Hemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15–70% of reported cases are fatal with no approved vaccine available. In the present study, the attenuated poxvirus vector, Modified Vaccinia virus Ankara, was used to develop a recombinant candidate vaccine expressing the CCHF virus nucleoprotein. Cellular and humoral immunogenicity was confirmed in 2 mouse strains, including type I interferon receptor knockout mice, which are susceptible to CCHF disease. Despite the immune responses generated post-immunisation, the vaccine failed to protect animals from lethal disease in a challenge model. Taylor & Francis 2015-08-26 /pmc/articles/PMC5049717/ /pubmed/26309231 http://dx.doi.org/10.1080/21645515.2015.1078045 Text en © 2016 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Research Papers Dowall, SD Buttigieg, KR Findlay-Wilson, SJD Rayner, E Pearson, G Miloszewska, A Graham, VA Carroll, MW Hewson, R A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease |
title | A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease |
title_full | A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease |
title_fullStr | A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease |
title_full_unstemmed | A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease |
title_short | A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease |
title_sort | crimean-congo hemorrhagic fever (cchf) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease |
topic | Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049717/ https://www.ncbi.nlm.nih.gov/pubmed/26309231 http://dx.doi.org/10.1080/21645515.2015.1078045 |
work_keys_str_mv | AT dowallsd acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT buttigiegkr acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT findlaywilsonsjd acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT raynere acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT pearsong acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT miloszewskaa acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT grahamva acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT carrollmw acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT hewsonr acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT dowallsd crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT buttigiegkr crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT findlaywilsonsjd crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT raynere crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT pearsong crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT miloszewskaa crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT grahamva crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT carrollmw crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease AT hewsonr crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease |